Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2001, p. 7470-7480, Vol. 21, No. 21
Department of Cell Biology, Harvard Medical
School, Boston, Massachusetts 02115
Received 30 August 2001/Returned for modification 11 October
2000/Accepted 27 July 2001
RSK is a serine/threonine kinase containing two distinct catalytic
domains. Found at the terminus of the Ras/extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) kinase cascade, mitogen-stimulated ribosomal S6 kinase (RSK)
activity requires multiple inputs. These inputs include phosphorylation
of the C-terminal kinase domain activation loop by ERK1/2 and
phosphorylation of the N-terminal kinase domain activation loop by
phosphoinositide-dependent protein kinase-1 (PDK1). Previous work has
shown that upon mitogen stimulation, RSK accumulates in the nucleus.
Here we show that prior to nuclear translocation, epidermal growth
factor-stimulated RSK1 transiently associates with the plasma membrane.
Myristylation of wild-type RSK1 results in an activated enzyme in the
absence of added growth factors. When RSK is truncated at the C
terminus, the characterized ERK docking is removed and RSK
phosphotransferase activity is completely abolished. When myristylated,
however, this myristylated C-terminal truncated form (myrCTT) is
activated at a level equivalent to myristylated wild-type (myrWT) RSK.
Both myrWT RSK and myrCTT RSK can signal to the RSK substrate c-Fos in
the absence of mitogen activation. Unlike myrWT RSK, myrCTT RSK is not
further activated by serum. Only the myristylated RSK proteins are
basally phosphorylated on avian RSK1 serine 381, a site critical for
RSK activity. The myristylated and unmyristylated RSK constructs
interact with PDK1 upon mitogen stimulation, and this interaction is
insensitive to the MEK inhibitor UO126. Because a kinase-inactive CTT
RSK can be constitutively activated by targeting to the membrane, we
propose that ERK may have a dual role in early RSK activation events:
preliminary phosphorylation of RSK and escorting RSK to a
membrane-associated complex, where additional MEK/ERK-independent activating inputs are encountered.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.21.7470-7480.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Regulatory Events Associated
with Membrane Targeting of p90 Ribosomal S6 Kinase 1
*
Corresponding author. Mailing address: Department of
Cell Biology, Harvard Medical School, 240 Longwood Ave., Boston, MA
02115. Phone: (617) 432-4848. Fax: (617) 432-1144. E-mail:
jblenis{at}hms.harvard.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|